Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial
Anaesthesiology Intensive Therapy · 30.06.2023 · 55 (2) · 103-108
DOI: 10.5114/ait.2023.129276 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anaesthesiology Intensive Therapy, online erschienen am 30.06.2023. Verfasst von Vaishnavi Bd und 6 weiteren Autor:innen. Beteiligte Einrichtung: All India Institute of Medical Sciences, Jodhpur, India. Hauptthemen laut MEDLINE: Dexmedetomidine, Ketamine, Midazolam, Premedication. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Paediatric patients are a population with a high level of anxiety. The prevention of perioperative stress in a frightened child is important to render the child calm and cooperative for smoother induction. Intranasal premedication is easy and safe, and the drug is rapidly absorbed into the systemic circulation, ensuring early onset of sedation in children and good effectiveness.
Methods
150 patients in the age group 2-4 years, ASA class I, undergoing elective surgical procedures were enrolled. The patients were randomly divided into 3 groups: a DM group (receiving intranasal dexmedetomidine 1 µg kg–1 and midazolam 0.12 mg kg–1), a DK group (receiving intranasal dexmedetomidine 1 µg kg–1 and ketamine 2 mg kg–1), and an MK group (receiving intranasal midazolam 0.12 mg kg–1 and ketamine 2 mg kg–1). After 30 minutes of administration of the drugs, the patients were assessed for parent separation anxiety, sedation, ease of IV cannulation, and mask acceptance.
Results
The comparison among the 3 groups showed a statistically significant difference for ease of IV cannulation and mask acceptance at 30 minutes, with a P-value of 0.010 with CI of 0.0–0.02, and P-value 0.007 with CI 0.0–0.02, respectively. The parent separation anxiety and sedation score at 30 minutes was statistically insignificant with a P-value of 0.82 with CI of 0.03–0.14 and P-value 0.631 with CI of 0.38–0.58, respectively.
Conclusions
The combination of midazolam and ketamine had a better clinical profile for premedication as compared to other combination drugs used in our study in terms of IV cannulation and acceptance of masks with a comparable decrease in separation anxiety from parents and adequate sedation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- All India Institute of Medical Sciences, Jodhpur, India.
- PGIMER, Chandigarh, India.
Zitieren
APA
Bd, V., Goyal, S., Sharma, A., Kothari, N., Kaloria, N., Sethi, P., & Bhatia, P. (2023). Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial. Anaesthesiology Intensive Therapy, 55(2), 103-108. https://doi.org/10.5114/ait.2023.129276
Vancouver
Bd V, Goyal S, Sharma A, Kothari N, Kaloria N, Sethi P, et al. Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial. Anaesthesiology Intensive Therapy. 2023;55(2):103-108. doi:10.5114/ait.2023.129276
BibTeX
@article{Bd2023,
author = {Bd, Vaishnavi and Goyal, Shilpa and Sharma, Ankur and Kothari, Nikhil and Kaloria, Narendra and Sethi, Priyanka and Bhatia, Pradeep},
title = {Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial},
journal = {Anaesthesiology Intensive Therapy},
year = {2023},
volume = {55},
number = {2},
pages = {103--108},
doi = {10.5114/ait.2023.129276}
}
EUVIMED